Latest chemotherapy Stories
BETHESDA, Md., Sept. 20, 2012 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for cancer, announced today that it is in late stage discussions with medical centers in the U.S. and Europe to proceed with a Phase I/II clinical trial with the Company's third major product line, DCVax(®)-Direct, for all types of solid tumor cancers (i.e., cancers in any tissues). The Company previously received...
A new study published in The Oncologist found that genetically engineered mouse models appear to be the most accurate preclinical predictor of how cancer-fighting drugs are delivered to melanoma patients. The study, led by UNC-Chapel Hill researchers along with colleagues in the Research Triangle Park, Pittsburgh and Austria, tested how four different types of mouse models predict the delivery of carboplatin, a commonly used anticancer drug, to melanoma tumors in patients. Durham, NC...
At St. Jude Children’s Research Hospital, patients use beads to mark treatment milestones, from losing their hair to completing chemotherapy, in a program other hospitals could tailor to meet the needs of their patients When Kayla Dehnert tells friends and family in Northern California about life as a St. Jude Children’s Research Hospital patient, she pulls out a string of beads taller than she is. “This is a learning-to-take medicine bead,” Kayla explains, fingering the bumps...
AMSTERDAM and IRVINE, Calif., Sept. 13, 2012 /PRNewswire/ -- Agendia, an innovative molecular cancer diagnostics company and leader in personalized medicine, announced today that they will present five posters on genomic research studies in breast cancer at the American Society of Clinical Oncology (ASCO) 2012 Breast Cancer Symposium. The meeting will be held from September 13-15, 2012 at the Marriott Marquis in San Francisco, California. Agendia's Symphony(TM) suite of molecular...
SAN FRANCISCO, Sept. 13, 2012 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive results of a large study that demonstrates the Oncotype DX® Recurrence Score® result to be a robust predictor of distant recurrence, disease-free survival, and overall survival in women with node-positive breast cancer who were treated with anthracycline-containing chemotherapy regimens. Highlighted in the official meeting presscast, these study results will be presented...
A new study from USC researchers is the first to show that controlled fasting improves the effectiveness of radiation therapy in cancer treatments, extending life expectancy in mice with aggressive brain tumors. Prior work by USC professor of gerontology and biological sciences Valter Longo, corresponding author on the study and director of the Longevity Institute at the USC Davis School of Gerontology, has shown that short-term fasting protects healthy cells while leaving cancer cells...
-Researchers enhance gene therapy approach for children with adenosine deaminase (ADA)-deficient severe combined immunodeficiency (SCID) using chemotherapy as conditioning regimen -For the first time, investigators test two different viral vectors to transport normal genes into the young patients' bone marrow stem cells and two different treatment plans in preparation for receiving gene therapy and compare outcomes WASHINGTON, Sept. 11, 2012 /PRNewswire-USNewswire/ -- By including...
April Flowers for redOrbit.com - Your Universe Online Two recent studies have shown real progress in killing cancer cells in dogs. The first study, from the University of Illinois at Urbana-Champaign, reports that myxoma, a pox virus that affects rabbits but not humans, dogs or other vertebrates studied so far, infects several different types of canine cancer cells in cell culture while sparing healthy cells. The study adds to the evidence that viruses or modified viruses will emerge as...
Following a report of 8-month-old Matthew Erickson, who developed brain cancer while in his mother’s womb, and his hopeful road to recovery through an aggressive chemotherapy treatment, Voices Against Brain Cancer releases a statement. Bohemia, NY (PRWEB) September 07, 2012 On September 7, 2012, nonprofit organization, Voices Against Brain Cancer, released a statement in response to 8-month-old Matthew Erickson’s exceptional battle against brain cancer: an optimistic and touching...
SAN CLEMENTE, Calif., Sept. 6, 2012 /PRNewswire/ -- ICU Medical, Inc. (Nasdaq:ICUI) today announced they will be hosting a presentation by Seth Eisenberg, RN, OCN(®), titled "Nurse Safety with Hazardous Drugs: Where Do You Stand?" to educate nurses about the dangers of exposure to hazardous drugs and examine methods for exposure prevention. This presentation to attendees of the International Conference on Cancer Nursing (ICCN) will be held at the Hilton Prague Hotel, Prague, CZ,...
Latest chemotherapy Reference Libraries
Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...
Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...
